loading
前日終値:
$40.14
開ける:
$40.18
24時間の取引高:
497.39K
Relative Volume:
0.43
時価総額:
$7.38B
収益:
$455.99M
当期純損益:
$-285.01M
株価収益率:
-12.23
EPS:
-3.26
ネットキャッシュフロー:
$-164.61M
1週間 パフォーマンス:
-0.23%
1か月 パフォーマンス:
-8.40%
6か月 パフォーマンス:
-7.36%
1年 パフォーマンス:
-30.48%
1日の値動き範囲:
Value
$39.33
$40.73
1週間の範囲:
Value
$36.92
$41.00
52週間の値動き範囲:
Value
$36.92
$70.13

Legend Biotech Corp Adr Stock (LEGN) Company Profile

Name
名前
Legend Biotech Corp Adr
Name
セクター
Healthcare (1195)
Name
電話
-
Name
住所
-
Name
職員
1,800
Name
Twitter
@LegendBiotech
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
LEGN's Discussions on Twitter

LEGN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
LEGN 39.85 7.38B 455.99M -285.01M -164.61M -3.26
VRTX 448.21 115.74B 10.63B -479.80M -1.35B 13.33
REGN 746.51 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.80 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.20 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.85 24.49B 3.30B -501.07M 1.03B 11.54

Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-12-19 開始されました Scotiabank Sector Perform
2023-11-06 開始されました Goldman Buy
2023-05-25 開始されました William Blair Mkt Perform
2023-05-22 開始されました Daiwa Securities Buy
2023-03-29 開始されました H.C. Wainwright Buy
2023-03-24 開始されました RBC Capital Mkts Outperform
2022-12-06 開始されました UBS Buy
2022-11-02 開始されました Evercore ISI Outperform
2022-11-01 開始されました Cowen Outperform
2022-10-31 開始されました Guggenheim Neutral
2022-06-17 開始されました BMO Capital Markets Outperform
2022-03-15 開始されました Barclays Overweight
2022-01-31 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-01-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-21 開始されました Piper Sandler Overweight
2021-05-18 開始されました BTIG Research Buy
2020-07-01 開始されました JP Morgan Overweight
2020-07-01 開始されました Jefferies Buy
2020-06-30 開始されました Morgan Stanley Overweight
すべてを表示

Legend Biotech Corp Adr (LEGN) 最新ニュース

pulisher
Nov 15, 2024

Legend Biotech stock hits 52-week low at $38.59 amid market shifts - Investing.com

Nov 15, 2024
pulisher
Nov 14, 2024

Legend Biotech's SWOT analysis: stock shows promise amid CAR-T therapy growth - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Legend Biotech shares steady with Overweight rating as Cantor raises target on Carvykti potential - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Legend Biotech shares steady with Overweight rating as Cantor raises target on Carvykti potential By Investing.com - Investing.com South Africa

Nov 14, 2024
pulisher
Nov 12, 2024

Earnings call: Legend Biotech sees robust growth in CARVYKTI sales - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Legend Biotech (LEGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance

Nov 12, 2024
pulisher
Nov 06, 2024

T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - GlobeNewswire Inc.

Nov 06, 2024
pulisher
Nov 05, 2024

Legend Biotech's SWOT analysis: carvykti success drives stock outlook - Investing.com

Nov 05, 2024
pulisher
Nov 04, 2024

Gilead Science to Report Q3 Earnings: What's in the Cards? - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Legend Biotech appoints new President for CARVYKTI - Investing.com

Nov 04, 2024
pulisher
Oct 28, 2024

Legend Biotech Corp ADR (NASDAQ:LEGN) Stock Is up 15.91% From Its Low, This Stock Is Just Warming Up - Stocks Register

Oct 28, 2024
pulisher
Oct 24, 2024

Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade - Yahoo Finance

Oct 24, 2024
pulisher
Oct 17, 2024

Adma Biologics Inc (ADMA) Should Be Considered For The Next Few Weeks - Stocks Register

Oct 17, 2024
pulisher
Oct 17, 2024

Legend Biotech shares hold Buy rating, $91 target despite Q3 CARVYKTI sales - Investing.com India

Oct 17, 2024
pulisher
Oct 17, 2024

Legend Biotech shares hold as Barclays maintains $94 target - Investing.com India

Oct 17, 2024
pulisher
Oct 16, 2024

Company’s Banking Stock: Dissecting a -18.35% Quarterly Revenue Decline Amid Growth - The InvestChronicle

Oct 16, 2024
pulisher
Oct 16, 2024

Redburn Atlantic initates Legend Biotech Corp ADR (LEGN) rating to a Buy - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Li Auto Inc ADR (LI) rating downgrades by Macquarie - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Recent Insider Activity Suggests Potential Gains for Enovix Corporation (ENVX) - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

BMO maintains steady target on Legend Biotech on strong sales - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

BMO maintains steady target on Legend Biotech on strong sales By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 15, 2024

Stock Performance Spotlight: Legend Biotech Corp ADR (LEGN) Ends the Day at 49.68, Down by -0.64 - The Dwinnex

Oct 15, 2024
pulisher
Oct 15, 2024

Legend Biotech Corp ADR’s results are impressive - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

UnitedHealth, NVIDIA lead Tuesday's afternoon market cap stock movers By Investing.com - Investing.com UK

Oct 15, 2024
pulisher
Oct 11, 2024

Legend Biotech maintains shares price target on steady Q3 growth - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Legend Biotech Corp ADR’s Mixed Bag: Down -8.63% in 6 Months, Down 1.03% in 30 Days - The InvestChronicle

Oct 11, 2024
pulisher
Oct 10, 2024

Market Insights: Legend Biotech Corp ADR (LEGN)’s Notable Gain of 1.62, Closing at 48.84 - The Dwinnex

Oct 10, 2024
pulisher
Oct 09, 2024

Legend Biotech shares hold strong with positive outlook on robust Carvykti sales - Investing.com

Oct 09, 2024
pulisher
Oct 08, 2024

Legend Biotech Corp ADR (LEGN) is a good investment, but the stock may be overvalued - US Post News

Oct 08, 2024
pulisher
Oct 08, 2024

Redburn sees growth potential for Legend Biotech stock on Carvykti demand - Investing.com

Oct 08, 2024
pulisher
Oct 07, 2024

Does Legend Biotech Corp ADR (LEGN) offer a good opportunity for investors? - SETE News

Oct 07, 2024
pulisher
Oct 04, 2024

Legend Biotech stock maintains positive outlook with new Philadelphia R&D facility - Investing.com

Oct 04, 2024
pulisher
Oct 03, 2024

Upward Trajectory: Legend Biotech Corp ADR (LEGN) Posts a Gaine, Closing at 48.68 - The Dwinnex

Oct 03, 2024
pulisher
Oct 02, 2024

Legend Biotech Corp ADR (LEGN) stock analysis: A simple moving average approach - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

You might want to take a look at Legend Biotech Corp ADR (LEGN) now - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

Legend Biotech shares maintain Buy rating from H.C. Wainwright By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

BMO maintains Outperform rating on Legend Biotech shares on Carvykti data - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Legend Biotech shares maintain Buy rating from H.C. Wainwright - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Legend Biotech's SWOT analysis: carvykti success drives stock potential - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Legend Biotech reiterates stock target, overweight on Phase III data - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Legend Biotech stock poised for growth with compelling data on Carvykti - Investing.com

Sep 30, 2024
pulisher
Sep 26, 2024

Legend Biotech Corp ADR (LEGN) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

Sep 26, 2024
pulisher
Sep 25, 2024

Can you now get a good deal on Legend Biotech Corp ADR’s shares? - US Post News

Sep 25, 2024
pulisher
Sep 24, 2024

There is no doubt that Legend Biotech Corp ADR (LEGN) ticks all the boxes. - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

Closing Bell Recap: Legend Biotech Corp ADR (LEGN) Ends at 45.92, Reflecting a -5.38 Downturn - The Dwinnex

Sep 24, 2024
pulisher
Sep 20, 2024

Analytical Lens: Exploring Legend Biotech Corp ADR (LEGN)’s Financial Story Through Ratios - The Dwinnex

Sep 20, 2024
pulisher
Sep 19, 2024

What was Legend Biotech Corp ADR (LEGN)’s performance in the last session? - US Post News

Sep 19, 2024
pulisher
Sep 18, 2024

European Investors Can Invest in the Future of U.S. Healthcare With This ETF - Trackinsight

Sep 18, 2024

Legend Biotech Corp Adr (LEGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):